Clinical Trial Update: Regional Tolvaptan Registry [Phase 4]

View source ↗

Summary

Phase 4 trial update for a regional registry evaluating tolvaptan in patients with decompensated heart failure and hyponatremia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Hyponatremia

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: Cardiology Research UBC | Conditions: Decompensated Heart Failure, Hyponatremia | Phase 4 | Status: UNKNOWN